Related references
Note: Only part of the references are listed.Epidemiology of heart failure with preserved ejection fraction: Results from the RICA Registry
Joan Carles Trullas et al.
MEDICINA CLINICA (2021)
Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study
Nathan K. Itoga et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Association of long-term SBP with clinical outcomes and quality of life in heart failure with preserved ejection fraction: an analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial
Peisen Huang et al.
JOURNAL OF HYPERTENSION (2021)
Prognostic value of ambulatory blood pressure values in elderly patients with heart failure. Results of the DICUMAP study
M. Camafort et al.
REVISTA CLINICA ESPANOLA (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
Alexandros Kasiakogias et al.
JOURNAL OF HYPERTENSION (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
Alice M. Jackson et al.
CIRCULATION (2020)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
Hypertension, heart failure, and frailty in older people: A common but unclear situation
Miguel Camafort et al.
JOURNAL OF CLINICAL HYPERTENSION (2020)
Effects of blood pressure lowering in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis
Hiroaki Kawano et al.
HYPERTENSION RESEARCH (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Differences in blood pressure riser pattern is patients with acute heart failure with reduced mid-range and preserved ejection fraction
Tomoya Ueda et al.
ESC HEART FAILURE (2019)
Heart Rate and Heart Failure With Preserved Ejection Fraction Time to Slow β-Blocker Use?
Markus Meyer et al.
CIRCULATION-HEART FAILURE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
Apostolos Tsimploulis et al.
JAMA CARDIOLOGY (2018)
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes
Kevin S. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure
Sang Eun Lee et al.
JACC-HEART FAILURE (2017)
Riser Pattern Is a Novel Predictor of Adverse Events in Heart Failure Patients With Preserved Ejection Fraction
Takahiro Komori et al.
CIRCULATION JOURNAL (2017)
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon et al.
EUROPEAN HEART JOURNAL (2016)
Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction
Angela B. S. Santos et al.
CIRCULATION-HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Dalane W. Kitzman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals
Arttu O. Lehtonen et al.
JOURNAL OF HYPERTENSION (2016)
Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure - meta-analyses of randomized trials
Costas Thomopoulos et al.
JOURNAL OF HYPERTENSION (2016)
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial
Elsayed Z. Soliman et al.
HYPERTENSION (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prognostic Significance of Left Atrial Enlargement in a General Population Results of the PAMELA Study
Michele Bombelli et al.
HYPERTENSION (2014)
Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial
Nigel Beckett et al.
JOURNAL OF HYPERTENSION (2014)
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people
Eleni Rapsomaniki et al.
LANCET (2014)
Role of ECG in the Diagnosis of Left Ventricular Hypertrophy
Ljuba Bacharova et al.
CURRENT CARDIOLOGY REVIEWS (2014)
Does Information on Systolic and Diastolic Function Improve Prediction of a Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension?
Giovanni de Simone et al.
HYPERTENSION (2010)
Regression of Left Ventricular Mass by Antihypertensive Treatment A Meta-Analysis of Randomized Comparative Studies
Robert H. Fagard et al.
HYPERTENSION (2009)
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients
Peter M. Okin et al.
ANNALS OF INTERNAL MEDICINE (2007)
Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction
Barry A. Borlaug et al.
CIRCULATION (2006)
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2006)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Change in diastolic left ventricular filling after one year of antihypertensive treatment -: The losartan intervention for endpoint reduction in hypertension (LIFE) study
K Wachtell et al.
CIRCULATION (2002)
Share Paper
